Literature DB >> 22893085

Intravitreal bevacizumab for peripapillary choroidal neovascular membranes.

Andrew S Davis, James C Folk, Stephen R Russell, Elliott H Sohn, Elliot H Sohn, H Culver Boldt, Edwin M Stone, Vinit B Mahajan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22893085     DOI： 10.1001/archophthalmol.2012.465

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN： 0003-9950


× No keyword cloud information.
  5 in total

1.  Management of Peripapillary Choroidal Neovascular Membrane in Patients With Idiopathic Intracranial Hypertension.

Authors:  Cem Ozgonul; Omar Moinuddin; Metasebia Munie; Michael S Lee; M Tariq Bhatti; Klara Landau; Gregory P Van Stavern; Devin D Mackay; Maud Lebas; Lindsey B DeLott; Wayne T Cornblath; Cagri G Besirli
Journal:  J Neuroophthalmol       Date:  2019-12       Impact factor: 3.042

2.  Peripapillary Choroidal Neovascularization Associated with Optic Nerve Head Drusen Treated with Anti-VEGF Agents.

Authors:  Norman A Saffra; Benjamin J Reinherz
Journal:  Case Rep Ophthalmol       Date:  2015-02-10

3.  Bevacizumab (Avastin) and Thermal Laser Combination Therapy for Peripapillary Choroidal Neovascular Membranes.

Authors:  Sean D Adrean; Scott Grant; Siyang Chaili
Journal:  J Ophthalmol       Date:  2017-03-26       Impact factor: 1.909

4.  Peripapillary Choroidal Neovascular Membrane Secondary to Sarcoidosis-Related Panuveitis: Treatment with Aflibercept and Ranibizumab with a 50-month Follow-Up.

Authors:  Artemis Matsou; Maria Dermenoudi; Despina Tzetzi; Tryfon Rotsos; Olga Makri; Eleftherios Anastasopoulos; Chrysanthos Symeonidis
Journal:  Case Rep Ophthalmol       Date:  2021-04-12

Review 5.  Cell-Matrix Interactions in the Eye: From Cornea to Choroid.

Authors:  Andrew E Pouw; Mark A Greiner; Razek G Coussa; Chunhua Jiao; Ian C Han; Jessica M Skeie; John H Fingert; Robert F Mullins; Elliott H Sohn
Journal:  Cells       Date:  2021-03-20       Impact factor: 7.666
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.